Mixed results mark the third quarter of 2025 for cannabis companies

While Trulieve records slight growth, MSOs like Verano and Cresco Labs face price compression and revenue contraction

Published on 11/07/2025

Resultados mistos marcam o terceiro trimestre de 2025 para empresas de cannabis

Prominent companies reported both declines and slight growths in their revenues, reflecting a volatile and highly competitive environment. Image: Canva Pro

The cannabis market presented a diversified financial scenario in the third quarter of 2025. Prominent companies reported both declines and slight growths in their revenues, reflecting a volatile and highly competitive environment.

Trulieve Cannabis Corp. stood out positively by recording a revenue of $288 million in the third quarter, marking a slight increase of 1%. The company demonstrated strong operational discipline, achieving a gross profit of $170 million - gross margin of 59%.

Despite the positive revenue, the company reported a net loss of $27 million. However, adjusted EBITDA reached $103 million - 36% of revenue - and operational cash flow remained robust at $77 million.

 

MSOs face challenges in the market

 

In contrast, other Multi-State Operators (MSOs) experienced revenue reductions. Verano Holdings Corp. announced a revenue of $203 million, a 6% decrease compared to the same period of the previous year (Q3 2024).

The company attributed this decrease mainly to "price compression and competition". Verano recorded a gross profit of $95 million - 47% of revenue - and a net loss of $44 million, with adjusted EBITDA of $53 million.

Following the downward trend, Cresco Labs Inc. reported a revenue of $165 million in the quarter, an 8% reduction. The company recorded a net loss of $22 million and an adjusted EBITDA of $40 million.

 

Real estate sector of the cannabis market also contracts

 

In the cannabis-focused real estate investment sector, Innovative Industrial Properties (IIPR), one of the leading REITs in the area, also saw its numbers contract.

IIPR announced a total revenue of $64.7 million, a 15% decrease. Nevertheless, the company reported a net income of $28.3 million and maintained quarterly dividend payments of $1.90 per share.

Notably, IIPR announced its first major investment outside the cannabis sector during the quarter, diversifying its portfolio.

 

With information from New Cannabis Ventures